Sugentech, Inc. of Cheongju-si, Chungcheongbuk-do at MEDICA 2018 in Düsseldorf -- COMPAMED Trade Fair

Sugentech, Inc.

721-26 Jeongjungyeonje-ro, Osong-eup, Heungdeok-gu, 28161 Cheongju-si, Chungcheongbuk-do
Korea, Republic
Telephone +82 2 22265282
Fax +82 43 7102880
info@sugentech.com

Hall map

MEDICA 2018 hall map (Hall 3A): stand 3AD55

Fairground map

MEDICA 2018 fairground map: Hall 3A

Contact

Lucio Kim

General Manager
Overseas Sales & Marketing

Seoul, Korea, Republic

Phone
0082-2-2226-5005

Email
luciokim@sugentech.com

Jiyoung Kwak

Deputy General Manager
Overseas Sales & Marketing

Seoul, Korea, Republic

Phone
0082-2-2226-5282

Email
jyoung@sugentech.com

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

About us

Company details

Sugentech, Inc. is the 28th INNOPOLIS Research Institute Spin-off Company of Ministry of Science and ICT in Korea and was established in 2011 based on the technology transfer from the ETRI (Electronics and Telecommunications Research Institute).

Since its establishment, Sugentech has accumulated various and robust bio- and nano- based technologies and successfully commercialized a variety of in- vitro diagnostic products. In 2017, K-MAC(bio department), an outstanding Korean semiconductor company became a Sugentech family, while bringing its full automation and IT technology and finally together making a comprehensive in-vitro diagnostic company with whole converging bio, nano and IT technology.

Now we are developing and selling products that can diagnose many types of diseases based on various platforms such as self-diagnostics home testing products (Self-testing), Point-of-care testing(POCT) products for rapid and accurate diagnosis in small and medium hospitals, and Fully Automated Immunoblot system for multiplex testing at large hospitals.

Based on its internalized bio-nano-IT convergence technology and commercialization capability, Sugentech enables early diagnosis of diseases which were not possible before, and is opening a new era of a personalized diagnosis through the development of micro, multiplex, automated diagnostic instruments.

 

More Less

Company data

Sales volume

10-49 Mio US $

Export content

> 75%

Number of employees

50-99

Foundation

2011

Area of business
  • Electromedical equipment / Medical Technology
  • Diagnostics